Mi S - Search Results

1

Inactivation of glycogen synthase kinase-3beta and up-regulation of LINGO-1 are involved in LINGO-1 antagonist regulated survival of cerebellar granular neurons.

Zhao XH, Jin WL, Wu J, Mi S, Ju G. Zhao XH, et al. Among authors: mi s. Cell Mol Neurobiol. 2008 Aug;28(5):727-35. doi: 10.1007/s10571-007-9258-6. Epub 2008 Jan 9. Cell Mol Neurobiol. 2008. PMID: 18183482

2

LINGO-1 antagonist promotes functional recovery and axonal sprouting after spinal cord injury.

Ji B, Li M, Wu WT, Yick LW, Lee X, Shao Z, Wang J, So KF, McCoy JM, Pepinsky RB, Mi S, Relton JK. Ji B, et al. Among authors: mi s. Mol Cell Neurosci. 2006 Nov;33(3):311-20. doi: 10.1016/j.mcn.2006.08.003. Epub 2006 Sep 29. Mol Cell Neurosci. 2006. PMID: 17011208

3

Combined effect of brain-derived neurotrophic factor and LINGO-1 fusion protein on long-term survival of retinal ganglion cells in chronic glaucoma.

Fu QL, Li X, Yip HK, Shao Z, Wu W, Mi S, So KF. Fu QL, et al. Among authors: mi s. Neuroscience. 2009 Aug 18;162(2):375-82. doi: 10.1016/j.neuroscience.2009.04.075. Epub 2009 May 5. Neuroscience. 2009. PMID: 19422885 Free article.

4

LINGO-1 regulates oligodendrocyte differentiation by inhibiting ErbB2 translocation and activation in lipid rafts.

Lee X, Shao Z, Sheng G, Pepinsky B, Mi S. Lee X, et al. Among authors: mi s. Mol Cell Neurosci. 2014 May;60:36-42. doi: 10.1016/j.mcn.2014.02.006. Epub 2014 Feb 28. Mol Cell Neurosci. 2014. PMID: 24583087

5

Inhibition of the leucine-rich repeat protein LINGO-1 enhances survival, structure, and function of dopaminergic neurons in Parkinson's disease models.

Inoue H, Lin L, Lee X, Shao Z, Mendes S, Snodgrass-Belt P, Sweigard H, Engber T, Pepinsky B, Yang L, Beal MF, Mi S, Isacson O. Inoue H, et al. Among authors: mi s. Proc Natl Acad Sci U S A. 2007 Sep 4;104(36):14430-5. doi: 10.1073/pnas.0700901104. Epub 2007 Aug 28. Proc Natl Acad Sci U S A. 2007. PMID: 17726113 Free PMC article.

6

LINGO-1 is a component of the Nogo-66 receptor/p75 signaling complex.

Mi S, Lee X, Shao Z, Thill G, Ji B, Relton J, Levesque M, Allaire N, Perrin S, Sands B, Crowell T, Cate RL, McCoy JM, Pepinsky RB. Mi S, et al. Nat Neurosci. 2004 Mar;7(3):221-8. doi: 10.1038/nn1188. Epub 2004 Feb 15. Nat Neurosci. 2004. PMID: 14966521

7

Blocking LINGO-1 function promotes retinal ganglion cell survival following ocular hypertension and optic nerve transection.

Fu QL, Hu B, Wu W, Pepinsky RB, Mi S, So KF. Fu QL, et al. Among authors: mi s. Invest Ophthalmol Vis Sci. 2008 Mar;49(3):975-85. doi: 10.1167/iovs.07-1199. Invest Ophthalmol Vis Sci. 2008. PMID: 18326721

8

LINGO-1 and its role in CNS repair.

Mi S, Sandrock A, Miller RH. Mi S, et al. Int J Biochem Cell Biol. 2008;40(10):1971-8. doi: 10.1016/j.biocel.2008.03.018. Epub 2008 Apr 1. Int J Biochem Cell Biol. 2008. PMID: 18468478 Review.

9

LINGO-1 negatively regulates TrkB phosphorylation after ocular hypertension.

Fu QL, Hu B, Li X, Shao Z, Shi JB, Wu W, So KF, Mi S. Fu QL, et al. Among authors: mi s. Eur J Neurosci. 2010 Mar;31(6):1091-7. doi: 10.1111/j.1460-9568.2010.07127.x. Eur J Neurosci. 2010. PMID: 20377621

10

LINGO-1 antagonists as therapy for multiple sclerosis: in vitro and in vivo evidence.

Rudick RA, Mi S, Sandrock AW Jr. Rudick RA, et al. Among authors: mi s. Expert Opin Biol Ther. 2008 Oct;8(10):1561-70. doi: 10.1517/14712598.8.10.1561. Expert Opin Biol Ther. 2008. PMID: 18774923 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

676 results

Search Page